fridays glp-1 reviews Health Review (Full Breakdown): My Verdict Fridays | GLP-1 Telehealth |
Description
Intention-to-treat analyses resulted in an HR of 1.36 (95% CI 0.51, 3.61)
New research indicates that maintaining meaningful weight loss after starting GLP-1-based therapies could play an important role in reducing the risk of multiple obesity-related diseases.
Mounjaro hit $23 billion, and Zepbound added $13.5 billion
Dual- and multi-receptor agonists may be a novel drug class to treat obesity and type 2 diabetes mellitus with high efficacy.
